Search Results 3291-3300 of 22495 for oral

  1. Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Participation eligibility · Treatment with systemic corticosteroids (including oral steroids)?. Yes _____ No ______ · Continuous use of topical steroid creams/ ...

  3. Merkel Cell Carcinoma Clinic - Overview

    A multispecialty team of doctors works together in your care. This is important for people with Merkel cell carcinoma, as each person's experience of the ...

  4. Mayo Clinic Q and A: Many conditions can cause feeling of burning in the mouth

    In some cases, oral surgeons or periodontists provide care for burning mouth syndrome. To find the right specialist for your father, contact his primary ...

  5. PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer - Mayo Clinic

    Results of the latter have demonstrated that after treatment with oral ... Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two ...

  6. Daniel M. Koffler, M.D. - Mayo Clinic Faculty Profiles

    Grant award, Psychedelic-Augmented Psychotherapy for Palliative Cancer Patients, 1440 Foundation, 2022-present. Investigational new drug approval, Ketamine Oral ...

  7. A Study to Evaluate the Safety and Tolerability of Rebiotix RBX2660 (microbiota suspension) in Subjects with Recurrent Clostridium difficile Infection - Mayo Clinic

    ... oral antibiotic therapy; or; has had at least two episodes of severe CDI resulting in hospitalization. A positive stool test for the presence of toxigenic C ...

  8. Early Detection Initiative for Pancreatic Cancer (EDI) - Mayo Clinic

    ... oral glucose tolerance test (OGTT) OR C. Any one (1) PDM present followed by an anti- diabetes medication ≤90 days after the index PDM date - Patient must ...

  9. Testosterone in Treating Postmenopausal Patients with Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment - Mayo Clinic

    Receiving anastrozole (1 mg) or letrozole (2.5 mg) orally once a day, for ≥ 21 days prior to registration ... oral or injectable vitamin D doses over 4,000 IU/ ...